Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.080
-0.040 (-3.57%)
At close: May 4, 2026, 4:00 PM EDT
1.075
-0.005 (-0.47%)
After-hours: May 4, 2026, 7:57 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.02 million as of May 4, 2026. Its market cap has increased by 47.96% in one year.
Market Cap
4.02M
Enterprise Value
-5.99M
1-Year Change
47.96%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.02M, a decrease of -95.56%. That is a compound annual growth rate of -43.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 4.17M | -12.06% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 4.80M |
| Pulmatrix | 4.71M |
| Matinas BioPharma Holdings | 4.48M |
| SciSparc | 4.47M |
| Ernexa Therapeutics | 4.45M |
| 60 Degrees Pharmaceuticals | 4.38M |
| Alzamend Neuro | 4.26M |
| AIM ImmunoTech | 4.20M |